These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14998987)

  • 1. Fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Russia: molecular mechanisms implicated.
    Vereshchagin VA; Ilina EN; Malakhova MV; Zubkov MM; Sidorenko SV; Kubanova AA; Govorun VM
    J Antimicrob Chemother; 2004 Apr; 53(4):653-6. PubMed ID: 14998987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance of Russian isolates of Neisseria gonorrhoeae to fluoroquinolones].
    Vereshchagin VA; Il'una EN; Malakhova MV; Zubkov MM; Sidorenko SV; Kubanova AA; Govorun VM
    Mol Gen Mikrobiol Virusol; 2005; (1):23-7. PubMed ID: 15790029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance-determining region mutations.
    Tiejun Z; Xiaoming Z; Jilun Z; Yinghu Z; Yanhua R; Yue C; Weiming G; Tao Z; Qingwu J
    Indian J Med Res; 2009 Jun; 129(6):701-6. PubMed ID: 19692753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
    Shigemura K; Shirakawa T; Okada H; Tanaka K; Udaka T; Kamidono S; Arakawa S; Gotoh A
    J Microbiol Methods; 2004 Dec; 59(3):415-21. PubMed ID: 15488283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on fluoroquinolone resistance and the relationship between resistance and mutations of gyrA and parC in Neisseria gonorrhoeae].
    Xu JS; Wang B; Wang CX; Gou HJ; Mi ZH; Ling JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug; 27(8):702-4. PubMed ID: 17172112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detection of the fluoroquinolone resistance-associated ParC mutation in Neisseria gonorrhoeae using TaqMan probes.
    Shigemura K; Shirakawa T; Tanaka K; Arakawa S; Gotoh A; Fujisawa M
    Int J Urol; 2006 Mar; 13(3):277-81. PubMed ID: 16643623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X; Lind I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
    Tanaka M; Nakayama H; Huruya K; Konomi I; Irie S; Kanayama A; Saika T; Kobayashi I
    Int J Antimicrob Agents; 2006 Jan; 27(1):20-6. PubMed ID: 16318912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between mutation of GyrA and ParC genes and quinolone resistance in Neisseria gonorrhoeae].
    Xie P; Mi ZH; Li Q; Zhang J; Xiao CY
    Zhonghua Nan Ke Xue; 2003; 9(4):275-8. PubMed ID: 12931370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
    Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
    J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.
    Tanaka M; Nakayama H; Notomi T; Irie S; Tsunoda Y; Okadome A; Saika T; Kobayashi I
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S15-22. PubMed ID: 15364300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries.
    Yong D; Kim TS; Choi JR; Yum JH; Lee K; Chong Y; Oh HB; Shultz T; Tapsall JW
    J Antimicrob Chemother; 2004 Aug; 54(2):451-5. PubMed ID: 15231766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.
    Giles JA; Falconio J; Yuenger JD; Zenilman JM; Dan M; Bash MC
    J Infect Dis; 2004 Jun; 189(11):2085-93. PubMed ID: 15143477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone resistance in Neisseria meningitidis in Spain.
    Enríquez R; Abad R; Salcedo C; Pérez S; Vázquez JA
    J Antimicrob Chemother; 2008 Feb; 61(2):286-90. PubMed ID: 18032423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
    Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
    BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
    Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
    Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.